Dr. Jeffrey R. Jay, M.D

Dr. Jeffrey R. Jay, M.D. as of March 31, 2012

Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.

Dr. Jeffrey R. Jay, M.D. holds 29 positions in its portfolio as reported in the March 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Keryx Biopharmaceuticals 10.4 $10M 2.1M 4.98
OncoGenex Pharmaceuticals 9.8 $9.8M 734k 13.29
Oncothyreon 8.6 $8.5M 2.0M 4.36
Santarus 7.5 $7.4M 1.3M 5.85
INC Ventrus Biosciences 6.2 $6.1M 613k 9.97
China Kanghui Holdings 6.0 $5.9M 313k 19.01
Insulet Corporation (PODD) 4.8 $4.8M 250k 19.14
Rigel Pharmaceuticals (RIGL) 4.8 $4.8M 592k 8.05
Abiomed 4.7 $4.7M 212k 22.19
Array BioPharma 4.2 $4.1M 1.2M 3.41
Vanda Pharmaceuticals (VNDA) 3.8 $3.7M 780k 4.79
Pozen 3.5 $3.5M 575k 6.00
Pain Therapeutics 3.1 $3.1M 850k 3.62
Gen-Probe Incorporated 3.0 $3.0M 45k 66.40
NPS Pharmaceuticals 2.5 $2.5M 2.1M 1.20
Palatin Technologies 2.4 $2.4M 3.3M 0.73
Amarin Corporation (AMRN) 2.3 $2.3M 204k 11.32
Biodel 2.2 $2.2M 3.7M 0.59
Merit Medical Systems (MMSI) 1.7 $1.7M 135k 12.42
Spectranetics Corporation 1.6 $1.6M 150k 10.40
Hansen Medical 1.5 $1.5M 500k 3.00
Cardica 1.5 $1.5M 695k 2.14
Discovery Laboratories 1.5 $1.5M 550k 2.68
Trius Therapeutics 1.0 $963k 180k 5.35
Natus Medical 0.6 $597k 50k 11.94
Tengion (TNGN) 0.5 $505k 902k 0.56
RTI Biologics 0.2 $241k 65k 3.71
EpiCept Corporation (EPCT) 0.0 $35k 166k 0.21
AMAG Pharmaceuticals 0.0 $2.0k 150.00 13.33